They are expressly not intended for veterinary or human utilization
Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
Manning P, Munasinghe PE, Bellae Papannarao J, Gray AR, Sutherland W, Katare R
Basic properties and clinical applications." Expert Opinion on Biological Therapy